Effects of Fruit Extracts on Glycaemia: The GLU-FRU Study

Postprandial Hyperglycemia Clinical Trial

— GLU-FRU  

Official title:

The Acute Effects of Blackcurrant and Apple Extracts on Postprandial Glycaemia: a Randomised Controlled Trial. The GLU-FRU Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02340039
• Other study ID #: GF2015
• Status: Completed
• Phase: N/A
• Start date: January 2015
• Est. completion date: July 2015

Study information

• Verified date: September 2019
• Source: King's College London
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Raised blood glucose levels can lead to adverse modifications to functional proteins within the body and eventually lead to the development of type 2 diabetes. Fruit polyphenols may help to control glycaemia following a carbohydrate meal or beverage. The aim of this study is to investigate the effects of blackcurrant (BC) and apple (A) extracts on postprandial glycaemia, insulinaemia and plasma gastric inhibitory polypeptide concentrations following a mixed carbohydrate test meal.

Description:

Introduction:

Diets with a high glycaemic load (a measure of the overall blood glucose-raising effect of a serving of a food) and containing high amounts of non-milk extrinsic sugars may contribute towards increased risk of developing type 2 diabetes (T2D). Raised blood glucose levels can lead to adverse modifications to functional proteins within the body and eventually lead to the development of T2D. Large peaks in blood glucose after a meal are a risk factor for T2D, and therefore it is desirable to consume a diet that will allow more gradual rises in blood glucose levels after meals. Fruit polyphenols may help to control glycaemia following a carbohydrate meal or beverage. Possible mechanisms include inhibition of intestinal enzymes and inhibition of intestinal glucose absorption by decreasing SGLT1/GLUT2 transport activity. The scientific literature also suggests that foods rich in polyphenols exert beneficial effects on risk factors of cardiovascular disease such as hypertension, lipid metabolism and vascular function.

Study Design:

A randomised, controlled, double-blind, cross-over study will be conducted. Subjects will receive combined blackcurrant and apple polyphenols, apple polyphenols only or placebo in random order at 3 separate study visits immediately before a high-carbohydrate meal. Seven days wash-out period will be required between study days.Standardised diet and exercise advice will be given prior to the visit. Subjects will arrive on each study visit between 09.00 and 10.00 h, after a 12 h overnight fast. They will then be cannulated in a forearm vein and baseline fasting blood samples will be taken in duplicate. All test drinks will be blended to be equal in volume, macronutrient and energy content. Fruit extracts instead of whole fruits will be administered to avoid the confounding effect of fruit fibre/viscosity on gastric emptying rate. Following consumption of the test drink, the high carbohydrate meal (starch and sucrose) will be served (white bread with apricot jam). Outcome variables will be measured postprandially until 120 min post-meal.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 34
• Est. completion date: July 2015
• Est. primary completion date: July 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years to 60 Years

Eligibility

Inclusion Criteria:

• Age: 20-60 y

• Male and female (post-menopausal only)

• Healthy (free of diagnosed diseases in the exclusion criteria)

• BMI 18-35 kg/m2

• Able to understand the information sheet and willing to comply with study protocol

• Able to give informed written consent

Exclusion Criteria:

• Those diagnosed with Phenylketonuria (PKU),

• Those with known or suspected food intolerances, allergies or hypersensitivity

• Women who are known to be pregnant or who are intending to become pregnant over the course of the study

• Women who are breast feeding

• Participation in another clinical trial

• Those who have donated blood within 3 months of the screening visit and participants for whom participation in this study would result in having donated more than 1500 millilitres of blood in the previous 12 months.

• Those with Full Blood Counts and Liver Function test results outside of the normal range (see table 1 below).

• Pre-menopausal women due to the potential influence of cyclical changes in reproductive hormones on insulin sensitivity

• Current smokers, or reported giving up smoking within the last 6 months

• History of substance abuse or alcoholism

• Reported history of CVD, diabetes (or fasting glucose = 7.1 mmol/L), cancer, kidney, liver or bowel disease, gastrointestinal disorder or use of drug likely to alter gastrointestinal function

• Unwilling to restrict consumption of specified high polyphenol foods for 24 h before the study

• Weight loss >3kg in preceding 2 months and body mass index <18 or >35 kg/m2

• Blood pressure =160/100 mmHg

• Total cholesterol = 7.5 mmol/L; fasting triacylglycerol concentrations = 5.0 mmol/L

• Medications that may interfere with the study such as alpha-glucosidase inhibitors (acarbose: Glucobay), insulin-sensitising drugs (metformin: Glucophage, Glucophage SR, Eucreas, Janumet; thiazolidinediones: Actos, Competact), sulfonylureas (Daonil, Diamicron MR, Glibenese, Minodiab, Amaryl Tolbutamide), and lipid-lowering drugs (statins, nicotinic acid, colestyramine anhydrous, ezetimibe, fibrates). Other medications should be reviewed by medical representative from KCL on a case by case basis.

• Nutritional supplements that may interfere with the study such as higher dose vitamins/minerals (>200% RNI), B vitamins, Vitamin C, calcium, copper, chromium, iodine, iron, magnesium, manganese, phosphorus, potassium and zinc. Subjects already taking vitamin or minerals at a dose around 100% or less up to 200% of the RNI, or evening primrose/algal/fish oil supplements will be asked to maintain habitual intake patterns, ensuring that they take them every day and not sporadically. They will be advised not to stop taking supplements or start taking new supplements during the course of the study.

Related Conditions & MeSH terms

• Hyperglycemia
• Postprandial Hyperglycemia

Intervention

Dietary Supplement:
• Polyphenols
Drinks will be delivered in random order at 3 separate study visits immediately before a high-carbohydrate meal. Seven days wash-out period will be required between study days.

Locations

Country	Name	City	State
United Kingdom	Metabolic Research Unit at King's College London. Franklin-Wilkins Buiding. Waterloo Campus	London	England

Sponsors (1)

Lead Sponsor	Collaborator
King's College London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postprandial glycaemia	Peak postprandial plasma glucose concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min	baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
Secondary	Postprandial insulinaemia	Peak postprandial insulin concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min	baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
Secondary	Postprandial glucose-dependent insulinotropic polypeptide (GIP) concentrations	Peak postprandial GIP concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min	baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
Secondary	Postprandial glucagon-like peptide-1 (GLP-1) concentrations	Peak postprandial GLP-1 concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min	baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
Secondary	Blood pressure	Change in the blood pressure after consumption of test drink	baseline and 60, 90 and 120 min following the test drink.
Secondary	Vascular function (Digital Volume Pulse; DVP)	Change in the tone of larger arteries (stiffness index) and small to medium-sized arteries (reflection index).	baseline and 60, 90 and 120 min following the test drink.
Secondary	Plasma non-esterified fatty acids (NEFA)	Peak postprandial NEFA concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min	baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.
Secondary	Plasma triglycerides (TAG)	Peak postprandial TAG concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min	baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.

External Links

•   Link